Home › Juvenile Arthritis › District of Columbia
Pag-aaral pangklinika para sa Juvenile Arthritis sa District of Columbia
4 pag-aaral para sa Juvenile Arthritis ang naghahanap ng mga kalahok sa mga site sa District of Columbia.
Mga Lungsod sa District of Columbia
Opisyal na teksto ng pag-aaral (English)
Study of Oral Upadacitinib and Subcutaneous/Intravenous Tocilizumab to Evaluate Change in Disease Activity, Adverse Events and How Drug Moves Through the Body of Pediatric and Adolescent Participants With Active Systemic Juvenile Idiopathic Arthritis.
- Childrens National Medical Center /ID# 253344, Washington D.C.
Nagre-recruitPhase 3
Edad 1 hanggang 17 · Lahat ng kasarian · Na-update Set 15, 2026 · NCT05609630A Study to Assess Adverse Events, Change in Disease Activity, and How the Drug Moves Through the Body in Children With Juvenile Psoriatic Arthritis (jPsA) Receiving Subcutaneously Injected Risankizumab or Adalimumab
- Childrens National Medical Center /ID# 259284, Washington D.C.
Nagre-recruitPhase 3
Edad 5 hanggang 17 · Lahat ng kasarian · Na-update Set 1, 2026 · NCT06100744Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry
- Childrens National Medical Center, Washington D.C.
Nagre-recruitObservasyonal na pag-aaral
Hanggang edad 21 · Lahat ng kasarian · Na-update Ago 27, 2026 · NCT02418442Development of a Therapeutic Endpoint in Pediatric Rheumatologic Conditions
- Children's National Health System, Washington D.C.
Nagre-recruitObservasyonal na pag-aaral
Edad 5 hanggang 21 · Lahat ng kasarian · Na-update Hul 24, 2026 · NCT04833465Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.